SG Americas Securities’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,409
| Closed | -$273K | – | 2674 |
|
|
2025
Q1 | $273K | Sell |
34,409
-33,965
| -50% | -$269K | ﹤0.01% | 2043 |
|
|
2024
Q4 | $866K | Buy |
+68,374
| New | +$866K | ﹤0.01% | 801 |
|
|
2024
Q3 | – | Sell |
-8,222
| Closed | -$113K | – | 2999 |
|
|
2024
Q2 | $113K | Buy |
+8,222
| New | +$113K | ﹤0.01% | 2173 |
|
|
2024
Q1 | – | Sell |
-64,692
| Closed | -$945K | – | 2658 |
|
|
2023
Q4 | $945K | Buy |
64,692
+27,712
| +75% | +$405K | 0.01% | 942 |
|
|
2023
Q3 | $454K | Buy |
36,980
+13,683
| +59% | +$168K | 0.01% | 1687 |
|
|
2023
Q2 | $278K | Buy |
23,297
+6,140
| +36% | +$73.3K | ﹤0.01% | 1440 |
|
|
2023
Q1 | $229K | Buy |
17,157
+4,018
| +31% | +$53.6K | ﹤0.01% | 2117 |
|
|
2022
Q4 | $283K | Buy |
13,139
+3,519
| +37% | +$75.8K | ﹤0.01% | 1764 |
|
|
2022
Q3 | $193K | Buy |
9,620
+174
| +2% | +$3.49K | ﹤0.01% | 2093 |
|
|
2022
Q2 | $169K | Buy |
+9,446
| New | +$169K | ﹤0.01% | 2535 |
|